The United Arab Emirates have announced that they have approved the emergency use for healthcare workers of a coronavirus vaccine still in the final phase of human trials. “The vaccine will be available to our first line of defense heroes who are at the highest risk of contracting the virus,”
tweeted the National Emergency Crisis and Disaster Management Authority (NCEMA) on Monday.
“Clinical trials for the third phase are continuing under the strict supervision of medical teams, while following all
measures to control the quality, safety and efficacy of the vaccine,” said NCEMA.
“The results of clinical trials in our country are moving on the right path, with all tests being successful so far.” NCEMA said the vaccine has been tested on 31,000 volunteers and only “mild and expected” side effects have been reported, adding that 1,000 test subjects with chronic diseases showed “no complications”.
“The Sinopham vaccine won approval from the Chinese government in June, and its phase one and two trials in the UAE saw all patients producing antibodies against the virus after two doses over four weeks” a UAE government statement said in July.
The UAE have increased its co-operation with China in recent years in areas including technology, defense procurement, trade, tourism and health. The UAE government statement States;
“Since the beginning of the pandemic the UAE has been in close cooperation with China around diagnostics, therapeutics and vaccines,” Taufiq Rahim, a senior fellow in the International Security program at New America, told CNBC on Tuesday. “It further reinforces the country’s unique role in having a close strategic relationship with the world’s two leading geopolitical rivals, China and the United States.”
Don’t forget to subscribe to Ghanaontheglobe.com for your accurate news updates in Ghana and around the world.